New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 10, 2014
07:32 EDTNBSNeoStem subsidiary announces bi-coastal facility expansions
NeoStem and its subsidiary, Progenitor Cell Therapy, announced that PCT has expanded both its Allendale, NJ and Mountain View, CA current Good Manufacturing Practice facilities to significantly increase its engineering and process development laboratories, and controlled environment space available for client needs. Furthermore, the expansion in the Allendale, NJ facility features an ISO Class 6/1,000 clean room, enabling PCT to manufacture products intended for European distribution.
News For NBS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 29, 2015
08:31 EDTNBSNeoStem plans to change name to Caladrius Biosciences
Subscribe for More Information
May 28, 2015
09:27 EDTNBSOn The Fly: Pre-market Movers
HIGHER: Rally Software (RALY), up 44% after deal to be bought by CA Technologies for $19.50 per share... IMAX (IMAX), up 6.5% after IMAX China files application for IPO on Hong Kong Stock Exchange... Avago (AVGO), up 2.8% after announcing deal to buy Broadcom (BRCM) for $37B in cash and stock. Broadcom shares are down 1% following the announcement... Western Digital (WDC), up 2.4% following upgrade to Buy from Neutral at Goldman. UP AFTER EARNINGS: Express (EXPR), up 8%... Abercrombie & Fitch (ANF), up 4.3%. LOWER: NeoStem (NBS), down 22.8% after 12.5M share secondary price at $2 per share... (CTRP), down 1.6% after reportedly disclosing cyberattack against its services. DOWN AFTER EARNINGS: Orbital ATK (OA), down 1.6%... Signet (SIG), down 3.5%... Sanderson Farms (SAFM), down 3%... Dangdang (DANG), down 11%.
May 27, 2015
19:14 EDTNBSOn The Fly: After Hours Movers
Subscribe for More Information
18:55 EDTNBSNeoStem 12.5M share Secondary priced at $2.00
Aegis acted as sole book running manager for the offering.
16:02 EDTNBSNeoStem files to sell common stock, no amount given
Aegis Capital Corp. is acting as sole book-running manager for the offering
May 26, 2015
07:33 EDTNBSNeoStem appoints Merrick Ross as lead for NeoStem's Intus study
Subscribe for More Information
May 21, 2015
15:19 EDTNBSNeoStem spikes higher, levels to watch
The shares are spiking sharply, last up more than 45% to $3.30. At that price next resistance is at the session high at $3.47 and then at $3.71. Support is at $3.17.
15:17 EDTNBSNeoStem up over 40% after getting $17.7M grant for metastatic melanoma treatment
Subscribe for More Information
15:15 EDTNBSNeoStem gets $17.7M grant for metastatic melanoma treatment
Subscribe for More Information
15:11 EDTNBSNeoStem gets $17.7M grant from CIRM

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use